研究者
J-GLOBAL ID：201801013844221315
更新日: 2024年02月21日
坪田 昭人
ツボタ アキヒト | Tsubota Akihito
所属機関・部署：
職名：
教授
競争的資金等の研究課題 (6件)：
論文 (357件)：
-
Chika Nakagawa, Tsunekazu Oikawa, Kohji Yamada, Akihito Tsubota, Chisato Saeki, Kuniko Katagiri, Naoko Tago, Hiroshi Kamioka, Kaoru Ueda, Koichiro Haruki, et al. Protein kinase C delta enhances the diagnostic performance of hepatocellular carcinoma. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 2024. 1-13
-
Haruyo Aoyagi, Hiroko Iijima, Eman S Gaber, Takuma Zaitsu, Mami Matsuda, Kosho Wakae, Koichi Watashi, Ryosuke Suzuki, Takahiro Masaki, Jeffrey Kahn, et al. Hepatocellular organellar abnormalities following elimination of hepatitis C virus. Liver international : official journal of the International Association for the Study of the Liver. 2023. 43. 8. 1677-1690
-
Chisato Saeki, Tomoya Kanai, Kaoru Ueda, Masanori Nakano, Tsunekazu Oikawa, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota. Insulin-like growth factor 1 predicts decompensation and long-term prognosis in patients with compensated cirrhosis. Frontiers in Medicine. 2023. 10
-
Masanori Atsukawa, Akihito Tsubota, Yuichi Tamura, Kaori Koyano-Shioda, Tadamichi Kawano, Tomomi Okubo, Korenobu Hayama, Taeang Arai, Norio Itokawa, Yu Taniguchi, et al. How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by portal hypertension? A post hoc analysis. JGH Open. 2023
-
Chisato Saeki, Tomoya Kanai, Kaoru Ueda, Masanori Nakano, Tsunekazu Oikawa, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota. Osteosarcopenia predicts poor survival in patients with cirrhosis: a retrospective study. BMC gastroenterology. 2023. 23. 1. 196-196
もっと見る
MISC (113件)：
-
及川恒一, 山田幸司, 坪田昭人, 佐伯千里, 上田薫, 神岡洋, 春木孝一郎, 池上徹, 吉田清嗣, 猿田雅之. 早期診断に有用な肝細胞癌特異的バイオマーカー血清PKCδ. 肝細胞研究会プログラム・抄録集. 2023. 30th
-
中野真範, 及川恒一, 木下勇次, 木下千夏, 富田陽一, 高野啓子, 石田仁也, 高倉一樹, 鳥巣勇一, 石川智久, et al. 当院におけるHIV/HCV重複感染例に対するDAA治療. 日本消化器病学会雑誌(Web). 2019. 116
-
Etsuko Iio, Noritomo Shimada, Kentaro Matsuura, Masanori Atsukawa, Koichi Takaguchi, Yuichiro Eguchi, Hideyuki Nomura, Noboru Hirashima, Akihito Tsubota, Atsunori Kusakabe, et al. Investigating the association of TLL1 variant with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free regimens. HEPATOLOGY. 2017. 66. 521A-521A
-
Taeang Arai, Masanori Atsukawa, Tadashi Ikegami, Shigeru Mikami, Noritomo Shimada, Akihito Tsubota, Keizo Kato, Hiroshi Abe, Tomomi Okubo, Ai Nakagawa, et al. Efficacy and safety of ombitasvir/ritonavir/paritaprevir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease. HEPATOLOGY. 2016. 64. 951A-951A
-
M. Atsukawa, N. Shimada, A. Tsubota, H. Abe, T. Okubo, A. Nakagawa, T. Arai, N. Itokawa, C. Kondo, Y. Tanaka, et al. EFFICACY OF DACLATASVIR/ASUNAPREVIR FOR PATIENTS WITH CHRONIC HEPATITIS C 1B COMPLICATED WITH RENAL INSUFFICIENCY. JOURNAL OF HEPATOLOGY. 2016. 64. S795-S795
もっと見る
書籍 (11件)：
-
Management of Gastric Cancer
InTech 2011
-
Nanocrystal
InTech 2011
-
ラクトフェリン 2007
2007
-
C型慢性肝炎治療の新たなストラテジー:インターフェロン治療の今後
先端医学社 2004
-
先端医療シリーズ25 肝・胆・膵疾患 肝・胆・膵疾患の最新医療
先端医療技術研究所 2004
もっと見る
前のページに戻る
